13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE Filed 2025-05-19 Event 2025-05-16 SEC 0000902664-25-002479 →

Matrix Capital Management Company, LP → Aura Biosciences, Inc. AURA

Stake: 11.17% Shares: 6,922,870 CUSIP: 05153U107 Class: Common Stock, par value $0.00001 per share
Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 40/100 · Filer 90d Win Rate: 50% · Hist. 90d Edge: +8.8%
  • Filer track record (3 filings): 50% 90d win rate, +8.8% 90d edge
  • High conviction ownership stake (11.2%)
  • Held by 1 tracked 13F institutional manager
  • 10 NPORT-P mutual funds holding CUSIP
  • Elevated short days-to-cover (10.6 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
4 13D/G filings on this issuer
3 other filings besides this one
Filer Track Record
4 filings by this filer
3 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 10.63
10,885,962 shares short · +5.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $298K
Point72 Asset Mgmt

Post-Filing Returns · since 2025-05-16 on AURA

+1 day
-0.5%
+5 days
+0.2%
+30 days
+7.6%
+60 days
+10.3%
+90 days
+17.6%
+180 days
-6.4%

Anchor price 5.95 on closest trading day on/after 2025-05-16. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Aura Biosciences, Inc.

FiledFormFilerStakeShares
2026-10-27 SCHEDULE 13G BlackRock, Inc. — — view →
2026-10-01 SCHEDULE 13G ForGrowth III PA B.V. — — view →
2026-05-11 SCHEDULE 13D/A Matrix Capital Management Company, LP — 0 view →

Other Filings by Matrix Capital Management Company, LP

FiledFormIssuerStakeShares
2026-05-11 SCHEDULE 13D/A Aura Biosciences, Inc. AURA — 0 view →
2026-01-02 SCHEDULE Zentalis Pharmaceuticals, Inc. ZNTL — — view →
2023-06-20 SC Zentalis Pharmaceuticals, Inc. ZNTL — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →